2019. A randomized, double blind, vehicle-controlled multicenter phase III study to evaluate the safety and efficacy of BF-200 ALA and narrowband red light in the treatment of superficial basal cell carcinoma (sBCC) with photodynamic therapy (PDT). SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S48. DOI:https://doi.org/10.25251/skin.3.supp.48.